← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #353 OF 1,000 MOST-CITED

Changes to Procedures Not Reviewed, Approved

FDA cited this observation 77 times across 73 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs77
BY FISCAL YEAR
FY20264
FY20251
FY20246
FY20235
FY20226
FY20213
FY20207
FY201910
FY20187
FY201715
FY201613

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 4.3× the rate of the average FDA-cited firm (32.9% vs 7.7%), across 73 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your Professional access…

How FDA worded it — real examples

Changes to written procedures are not reviewed and approved by the quality control unit.

CSL Behring GmbH · Marburg · Drugs · 2026-02-18

Changes to written procedures are not drafted, reviewed and approved by the appropriate organizational unit and reviewed and approved by the quality control unit.

PTI Georgia, LLC · Royston, Georgia · Drugs · 2026-01-16

Changes to written procedures are not drafted, reviewed and approved by the appropriate organizational unit and reviewed and approved by the quality control unit.

Merle Norman Cosmetics, Inc. · Los Angeles, California · Drugs · 2025-11-21

Changes to written procedures are not drafted, reviewed and approved by the appropriate organizational unit and reviewed and approved by the quality control unit.

Chartwell Pharmaceuticals Congers, LLC · Congers, New York · Drugs · 2025-11-18

Changes to written procedures are not drafted, reviewed and approved by the appropriate organizational unit and reviewed and approved by the quality control unit.

Societa' Italiana Progetti Ricerche E Sviluppo SRL · Limena · Drugs · 2025-01-23

Changes to written procedures are not drafted, reviewed and approved by the appropriate organizational unit.

Choice All Natural Inc D · Apex, North Carolina · Drugs · 2024-02-26

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharmaceutical quality systemPharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →